General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Medtronic(SIGNIFICANT), Boston Scientific(SIGNIFICANT), Janssen Pharmaceuticals, Inc(SIGNIFICANT), Venture Medical Group(SIGNIFICANT), Inari(MODEST), Abbott Laboratories(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Philips(SIGNIFICANT), Endovascular Engineering(SIGNIFICANT), Teleflex(MODEST), Shockwave(SIGNIFICANT), Cordis(SIGNIFICANT), Gore(SIGNIFICANT), InfraRedx(MODEST), RapidAI(MODEST), Siemens(MODEST), Terumo(SIGNIFICANT), Zoll(MODEST), Rampart(MODEST), Asahi(SIGNIFICANT), Conavi(MODEST), Penumbra(MODEST), R3 Vascular(SIGNIFICANT), Regeneron(SIGNIFICANT), Evident Engineering(MODEST), Thrombolex(MODEST) SPEAKER'S BUREAU: Cook(SIGNIFICANT), BD Bard(MODEST) RESEARCH/RESEARCH GRANTS: Medtronic(SIGNIFICANT), Cook(SIGNIFICANT), BD Bard(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Philips(SIGNIFICANT), Boston Scientific(SIGNIFICANT), Laminate Medicial(SIGNIFICANT), Abbott Laboratories(NONE)
